Medication Safety Concerns Surrounding Immunomodulators

被引:0
|
作者
Farber, Margo S. [1 ]
机构
[1] Univ Michigan Hlth Syst, Dept Pharm Serv, Drug Informat Serv, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The number of medications used to manage autoimmune disorders has increased dramatically. These agents-the immunomodulators-have resulted in improvements in patient outcomes and, in some cases, slowing of disease progression. Despite these advances, immunomodulators are also associated with substantial medication-safety concerns. The potential for adverse drug reactions, serious drug-related complications, and medication errors is significant. Pharmacists must be acutely aware of immunomodulators' complexity and associated potential for adverse events. Attention to all aspects of the medication-use process-procurement and storage, prescribing, dispensing, administration, and monitoring-is required to assure that these agents are used in the safest and most efficacious manner.
引用
收藏
页码:HS2 / +
页数:5
相关论文
共 50 条
  • [41] PPI safety concerns
    Khokhar, Nasir
    RAWAL MEDICAL JOURNAL, 2012, 37 (01): : 1 - +
  • [42] CELLULAR SAFETY CONCERNS
    LEVINE, S
    IEEE SPECTRUM, 1993, 30 (10) : 7 - 7
  • [43] Safety concerns with Fluoroquinolones
    Mehhorn, Allana J.
    Brown, Dana A.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (11) : 1859 - 1866
  • [44] Medication safety
    Keohane, Carol A.
    Bates, David W.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2008, 35 (01) : 37 - +
  • [45] Safety of Immunomodulators and Anti-TNF Therapy in Pregnancy
    Khadija H. Chaudrey
    Sunanda V. Kane
    Current Treatment Options in Gastroenterology, 2015, 13 (1) : 77 - 89
  • [46] Social stigma concerns and HIV medication adherence
    Rintamaki, Lance S.
    Davis, Terry C.
    Skripkauskas, Silvia
    Bennett, Charles L.
    Wolf, Michael S.
    AIDS PATIENT CARE AND STDS, 2006, 20 (05) : 359 - 368
  • [47] The Safety Dance: Medication Safety and Me
    MacKinnon, Neil J.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2008, 61 : 29 - 30
  • [48] Safety concerns over Crestor
    Butler, R
    CHEMISTRY & INDUSTRY, 2004, (06) : 5 - 5
  • [49] Antipsychotic safety and efficacy concerns
    Meyer, Jonathan M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 : 20 - 26
  • [50] Analysis of Staff Safety Concerns
    Davidson, Judy
    Lamontagne, Gena
    Burnell, Lori
    Saks, Nancy
    Vespe, Marlys
    Schloeder, Diane
    Layne, Tracy
    JOURNAL OF NURSING CARE QUALITY, 2013, 28 (02) : 147 - 152